What is Bby?
Bby is a company dedicated to revolutionizing infant nutrition by ensuring safe and affordable access to natural breast milk. Recognizing the critical importance of breast milk for infant development, Bby addresses concerns from mothers with insufficient supply and LGBTQ+ couples unable to produce milk. The company has developed an innovative process to create 100% bioactive condensed milk, maintaining the nutritional and immunological benefits of fresh breast milk. This advancement aims to improve health outcomes for infants, minimize waste in hospitals, and reduce costs.
How much funding has Bby raised?
Bby has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2023): $3M with participation from Y Combinator, Pioneer Fund, and Cathexis Ventures
Key Investors in Bby
Y Combinator
Y Combinator is a renowned startup accelerator that provides seed funding and mentorship to early-stage companies, helping them to grow and scale their businesses.
Pioneer Fund
Pioneer Fund, backed by Y Combinator alumni, offers capital, expertise, and strategic connections to founders, focusing on future-oriented ventures and aiming for rapid decision-making.
Cathexis Ventures
Cathexis Ventures is an early-stage venture capital firm that invests in founders tackling significant challenges, with a focus on building user-centric products and fostering sustainable growth.
What's next for Bby?
With this major strategic investment, Bby is poised to scale its operations and further its mission of nurturing the future of infant nutrition. The company's focus on scientific innovation, particularly in milk processing and administration, suggests a trajectory towards becoming a leader in the healthcare and biotechnology sectors. Future developments may include expanding its hospital partnerships, further research into milk science, and potentially exploring new applications for its bioactive condensed milk technology.
See full Bby company page
